Log In or Create Account
Resistance Mutations
Podcasts
Key Slides
Question of the Week
CROI
RWHAP Clinical Conference
Donate
Contact
Advanced Search
CME Courses
HIV In-Person and Virtual Courses
Current On-Demand Courses
About Courses
CME Webinars
Upcoming Webinars
Current On-Demand Webinars
MATE Act CME
About Webinars
Dialogues
Upcoming IAS–USA Dialogues
On-Demand Dialogues
About Dialogues
Topics In Antiviral Medicine
Current Issues for CME
Previous Issues
TAM
Policies and Practices
Permission Request Form
Did You Know?
FAQs
Fellow/Student Resources
Fellow/Student Resources
IAS-USA Guidelines
On-Demand Webcasts
Research Collaborations
Additional Resources
About
Mission
Scientific Leadership Board
Core Faculty
IAS-USA Award Recipients
Staff
CME
Funding Information
Careers
Website Policies
Governance
FAQs
Menu
Archives:
TAM Issues
Mar
01
March/April 2008
DETAIL
Nov
01
November/December 2007
DETAIL
Aug
01
August/September 2007
DETAIL
Jun
01
June/July 2007
DETAIL
Apr
01
April/May 2007
DETAIL
Feb
01
February/March 2007
DETAIL
Dec
01
December 2006/January 2007
DETAIL
Oct
01
October/November 2006
DETAIL
Aug
01
August/September 2006
DETAIL
Jun
01
June/July 2006
DETAIL
Page 9 of 15
« First
«
...
7
8
9
10
11
...
»
Last »
Resistance Mutations
Podcasts
Key Slides
Question of the Week
CROI
RWHAP Clinical Conference
Donate
Contact
CME Courses
HIV In-Person and Virtual Courses
Current On-Demand Courses
About Courses
CME Webinars
Upcoming Webinars
Current On-Demand Webinars
MATE Act CME
About Webinars
Dialogues
Upcoming IAS–USA Dialogues
On-Demand Dialogues
About Dialogues
Topics In Antiviral Medicine
Current Issues for CME
Previous Issues
TAM
Policies and Practices
Permission Request Form
Did You Know?
FAQs
Fellow/Student Resources
Fellow/Student Resources
IAS-USA Guidelines
On-Demand Webcasts
Research Collaborations
Additional Resources
About
Mission
Scientific Leadership Board
Core Faculty
IAS-USA Award Recipients
Staff
CME
Funding Information
Careers
Website Policies
Governance
FAQs
Practice Question of the Week
March 25, 2024: Acute HIV Infection and Long-Acting Early Viral Inhibition
Which statement accurately contrasts acute HIV infection (AHI) with long-acting early viral inhibition (LEVI) in the context of HIV?
A. AHI is characterized by explosive viral replication immediately following infection, whereas LEVI involves smoldering viral replication due to long-acting antiviral preexposure prophylaxis (PrEP) agents
B. LEVI is typically detected through standard antigen/antibody assays, RNA assays, and DNA assays
C. LEVI is associated with a high likelihood of HIV transmission
D. Drug resistance is a common feature of AHI because of natural infection dynamics
Watch On-Demand Webcast
View Archived Questions
Leave Feedback
Subscribe
CLOSE